BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17129830)

  • 21. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computation of the physio-chemical properties and data mining of large molecular collections.
    Cheng A; Diller DJ; Dixon SL; Egan WJ; Lauri G; Merz KM
    J Comput Chem; 2002 Jan; 23(1):172-83. PubMed ID: 11913384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge-based approaches in the design and selection of compound libraries for drug discovery.
    Viswanadhan VN; Balan C; Hulme C; Cheetham JC; Sun Y
    Curr Opin Drug Discov Devel; 2002 May; 5(3):400-6. PubMed ID: 12058615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Database systems for knowledge-based discovery.
    Jagarlapudi SA; Kishan KV
    Methods Mol Biol; 2009; 575():159-72. PubMed ID: 19727614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming the work of early-stage drug discovery through bioprocess informatics.
    Holzman TF; Hebert EJ
    Drug Discov Today; 2005 Jan; 10(1):61-7. PubMed ID: 15676300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palladium coupling catalysts for pharmaceutical applications.
    Doucet H; Hierso JC
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):672-90. PubMed ID: 17987520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chem-tox informatics: data mining using a medicinal chemistry building block approach.
    Johnson DE; Blower PE; Myatt GJ; Wolfgang GH
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):92-101. PubMed ID: 11727328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clustering and its application in multi-target prediction.
    Liu W; Johnson DE
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):98-107. PubMed ID: 19152218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A practical view of 'druggability'.
    Keller TH; Pichota A; Yin Z
    Curr Opin Chem Biol; 2006 Aug; 10(4):357-61. PubMed ID: 16814592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for dealing with metabolite elucidation in drug discovery and development.
    Nassar AE; Talaat RE
    Drug Discov Today; 2004 Apr; 9(7):317-27. PubMed ID: 15037231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ; Ertl P; Lewis R
    Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex molecules: do they add value?
    Selzer P; Roth HJ; Ertl P; Schuffenhauer A
    Curr Opin Chem Biol; 2005 Jun; 9(3):310-6. PubMed ID: 15939334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.